Stem Cells in Rapidly Evolving Active Multiple Sclerosis

NCT01606215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Mesenchymal stem cells
DRUG: Placebo

Sponsor

Imperial College London